Digital CBT for Insomnia in Healthcare Workers
(HCW-CBTi Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a digital therapy program designed to help healthcare workers struggling with sleep due to job stress during the COVID-19 pandemic. The program, called digital Cognitive Behavioral Therapy for insomnia (CBTi), is delivered through an app to improve sleep, mental health, and overall well-being. Participants will either begin the digital therapy immediately or after 12 weeks of using sleep education resources. Healthcare workers involved in frontline patient care who have trouble sleeping and internet access are ideal candidates for the trial. As an unphased trial, this study offers healthcare workers the chance to explore innovative digital solutions for better sleep and well-being.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are participating in other psychological treatments or drug trials, you would not be eligible for this study.
What prior data suggests that digital CBTi is safe for healthcare workers?
Research has shown that digital Cognitive Behavioral Therapy for Insomnia (dCBTi) is generally safe for most people. Studies have found that dCBTi not only improves sleep but also enhances overall mental health. For instance, users of digital CBT have reported better sleep quality and longer sleep duration.
Importantly, dCBTi is non-invasive, meaning it doesn't involve surgery or medications, which reduces the risk of side effects. Clinical evidence suggests that dCBTi often surpasses medication in treating insomnia, offering long-term benefits with fewer side effects.
In summary, current research supports that dCBTi is well-tolerated, with few reported negative effects. This makes it a safe option for many people seeking to improve their sleep.12345Why are researchers excited about this trial?
Researchers are excited about Digital Cognitive Behavioral Therapy for Insomnia (dCBTi) because it offers a modern, accessible approach to managing insomnia, especially for healthcare workers. Unlike traditional therapies that might involve face-to-face sessions or medication, dCBTi leverages the Sleepio™ app and website to deliver therapy through a convenient digital platform. This method allows users to access therapy on their own schedule, making it flexible and potentially more engaging. Moreover, it eliminates the need for medication, reducing the risk of side effects and dependency.
What evidence suggests that digital CBTi is effective for improving sleep health in healthcare workers?
Research has shown that Digital Cognitive Behavioral Therapy for Insomnia (dCBTi) improves sleep. Studies have found that dCBTi can reduce insomnia symptoms and enhance sleep quality for many people. For example, one study discovered that digital therapy effectively treated insomnia without sleep medication. Another study noted that dCBTi was especially beneficial for older adults by making insomnia treatment more accessible. In this trial, participants in the intervention arm will receive dCBTi through the Sleepio™ app, which uses proven CBTi techniques and offers a flexible way to address sleep problems. This approach is a promising option for those struggling with insomnia, such as healthcare workers facing stress from the pandemic.16789
Who Is on the Research Team?
Mandeep Singh, MD, FRCPC
Principal Investigator
Associate Professor, Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, UHN
Are You a Good Fit for This Trial?
This trial is for frontline healthcare workers experiencing insomnia, with a score of 16 or lower on the Sleep Condition Indicator. They must be actively involved in patient care during the COVID-19 pandemic and have access to a mobile phone or computer with internet. Those with urgent CBT needs, recent CBT treatment, additional sleep disorders like apnea or restless legs syndrome, severe medical/psychiatric conditions, or participating in other treatments/drug trials are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in the intervention arm receive digital CBTi via the Sleepio app over 6 to 12 weeks, while the control group accesses sleep diary and education material for 12 weeks.
Follow-up
Participants are monitored for changes in sleep health, mental health, and overall quality of life after the treatment phase.
What Are the Treatments Tested in This Trial?
Interventions
- Digital Cognitive Behavioral Therapy for Insomnia (dCBTi)
Trial Overview
The study tests if digital Cognitive Behavioral Therapy for Insomnia (dCBTi) can improve sleep health, mental well-being, and quality of life among healthcare workers caring for COVID-19 patients. It's a Canada-wide randomized controlled trial comparing dCBTi's effectiveness against usual care practices.
How Is the Trial Designed?
2
Treatment groups
Active Control
Participants in the control group will have access to online the sleep diary and sleep education material for 12 weeks, without the CBTi intervention by the Sleepio™ app (Big Health Ltd., London, UK). They will start the digital cognitive behavioral therapy for insomnia (dCBTi) intervention 12 weeks after the initial enrollment.
Digital CBTi will be offered using the SleepioTM website and supporting Sleepio™ app (Big Health Ltd., London, UK) via 6 sessions training program (spanning 6 to 12 weeks), lasting an average of 20 minutes each, unlocked weekly. The participant will receive the Sleepio intervention as soon as they become assigned.
Digital Cognitive Behavioral Therapy for Insomnia (dCBTi) is already approved in Canada, United States, European Union for the following indications:
- Insomnia
- Insomnia
- Insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
Published Research Related to This Trial
Citations
Digital Cognitive Behavioral Therapy (dCBT) for Insomnia
Consistent evidence has been published on the effectiveness of dCBT to address insomnia disorder, in a variety of populations, with effects extending into well ...
Effectiveness of digital cognitive-behavioral therapy for ...
The findings of this study demonstrate that digital therapy, combined or not with sleep medication, is effective for the treatment of insomnia. Our findings ...
Innovative Digital Cognitive Behavioral Treatment for ...
Methods: The program was constructed based on validated CBT-i theory and practice, incorporating the latest scientific data on CBT for insomnia.
Nurse-Supported Self-Directed Cognitive Behavioral ...
This randomized clinical trial examines the effectiveness of a nurse-supported, self-directed behavioral insomnia intervention for ...
A randomized controlled trial of a digital cognitive ...
Results indicate that digital CBT-I provides important benefits for older adults, offering strong potential to expand access to insomnia ...
Assessing the Short-Term Efficacy of Digital Cognitive ...
This study examines whether adding chatbot-based and human coaching would improve the treatment efficacy of, and adherence to, dCBTi.
Digital Cognitive Behavioral Therapy vs Medication ...
In this study, clinical evidence suggested that combination therapy was optimal, and dCBT-I was more effective than medication therapy, with long-term benefits ...
Digital cognitive behavioural therapy for insomnia reduces ...
The existing literature indicates that digital CBT and CBT‐I can improve clinical outcomes in mental health in general as well as in insomnia disorder, ...
Internet-delivered Cognitive Behavioral Therapy for Insomnia
confirmed that eCBT-I significantly improves insomnia severity, sleep efficiency, sleep quality, latency, and total sleep time, achieving ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.